These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
728 related articles for article (PubMed ID: 16933325)
1. Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis. Nathan SS; Gorlick R; Bukata S; Chou A; Morris CD; Boland PJ; Huvos AG; Meyers PA; Healey JH Cancer; 2006 Oct; 107(7):1607-16. PubMed ID: 16933325 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma. Ferrari S; Bertoni F; Zanella L; Setola E; Bacchini P; Alberghini M; Versari M; Bacci G Cancer; 2004 May; 100(9):1936-42. PubMed ID: 15112275 [TBL] [Abstract][Full Text] [Related]
3. Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients. Bacci G; Longhi A; Cesari M; Versari M; Bertoni F Cancer; 2006 Jun; 106(12):2701-6. PubMed ID: 16691623 [TBL] [Abstract][Full Text] [Related]
4. Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy. Hawkins DS; Arndt CA Cancer; 2003 Dec; 98(11):2447-56. PubMed ID: 14635080 [TBL] [Abstract][Full Text] [Related]
5. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience. Mialou V; Philip T; Kalifa C; Perol D; Gentet JC; Marec-Berard P; Pacquement H; Chastagner P; Defaschelles AS; Hartmann O Cancer; 2005 Sep; 104(5):1100-9. PubMed ID: 16015627 [TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients. Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG Ann Surg Oncol; 2008 Mar; 15(3):906-14. PubMed ID: 18163171 [TBL] [Abstract][Full Text] [Related]
7. [Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy]. Zhang Q; Niu XH; Cai YB; Hao L; Ding Y Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(16):1114-7. PubMed ID: 18005614 [TBL] [Abstract][Full Text] [Related]
8. Treatment of osteosarcoma at first recurrence after contemporary therapy: the Memorial Sloan-Kettering Cancer Center experience. Chou AJ; Merola PR; Wexler LH; Gorlick RG; Vyas YM; Healey JH; LaQuaglia MP; Huvos AG; Meyers PA Cancer; 2005 Nov; 104(10):2214-21. PubMed ID: 16206297 [TBL] [Abstract][Full Text] [Related]
9. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery? Jaffe N; Carrasco H; Raymond K; Ayala A; Eftekhari F Cancer; 2002 Nov; 95(10):2202-10. PubMed ID: 12412175 [TBL] [Abstract][Full Text] [Related]
10. Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma. Harting MT; Blakely ML; Jaffe N; Cox CS; Hayes-Jordan A; Benjamin RS; Raymond AK; Andrassy RJ; Lally KP J Pediatr Surg; 2006 Jan; 41(1):194-9. PubMed ID: 16410132 [TBL] [Abstract][Full Text] [Related]
11. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience. Asoglu O; Karanlik H; Muslumanoglu M; Igci A; Emek E; Ozmen V; Kecer M; Parlak M; Kapran Y Eur J Surg Oncol; 2007 Dec; 33(10):1199-206. PubMed ID: 17400423 [TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis. Kaya M; Wada T; Akatsuka T; Kawaguchi S; Nagoya S; Shindoh M; Higashino F; Mezawa F; Okada F; Ishii S Clin Cancer Res; 2000 Feb; 6(2):572-7. PubMed ID: 10690541 [TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Bacci G; Longhi A; Versari M; Mercuri M; Briccoli A; Picci P Cancer; 2006 Mar; 106(5):1154-61. PubMed ID: 16421923 [TBL] [Abstract][Full Text] [Related]
15. Free osseous and soft tissue surgical margins as prognostic factors in mandibular osteosarcoma. Granados-Garcia M; Luna-Ortiz K; Castillo-Oliva HA; Villavicencio-Valencia V; Herrera-Gómez A; Mosqueda-Taylor A; Aguilar-Ponce JL; Poitevin-Chacón A Oral Oncol; 2006 Feb; 42(2):172-6. PubMed ID: 16246617 [TBL] [Abstract][Full Text] [Related]
17. Radiotherapy for local control of osteosarcoma. DeLaney TF; Park L; Goldberg SI; Hug EB; Liebsch NJ; Munzenrider JE; Suit HD Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):492-8. PubMed ID: 15667972 [TBL] [Abstract][Full Text] [Related]
18. Pulmonary resection for metastatic osteosarcomas: a retrospective analysis of 21 patients. Pfannschmidt J; Klode J; Muley T; Hoffmann H; Dienemann H Thorac Cardiovasc Surg; 2006 Mar; 54(2):120-3. PubMed ID: 16541354 [TBL] [Abstract][Full Text] [Related]
19. Resection of recurrent pulmonary metastases in patients with osteosarcoma. Briccoli A; Rocca M; Salone M; Bacci G; Ferrari S; Balladelli A; Mercuri M Cancer; 2005 Oct; 104(8):1721-5. PubMed ID: 16155943 [TBL] [Abstract][Full Text] [Related]
20. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). Kempf-Bielack B; Bielack SS; Jürgens H; Branscheid D; Berdel WE; Exner GU; Göbel U; Helmke K; Jundt G; Kabisch H; Kevric M; Klingebiel T; Kotz R; Maas R; Schwarz R; Semik M; Treuner J; Zoubek A; Winkler K J Clin Oncol; 2005 Jan; 23(3):559-68. PubMed ID: 15659502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]